Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Abolaji Samson Olagunju has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bioactive compounds and Pharmacological properties of Portulaca oleracea

    by John Oluwafemi Teibo, Benjamin Ayodipupo Babalola, Abolaji Samson Olagunju, Athanasios Alexiou, Marios Papadakis, Gaber El-Saber Batiha


  • Open Access

    Memory T Cells, Recombinant Listeria monocytogenes, and Cancer Vaccines

    by Abolaji Samson Olagunju, Maribel Limachi Loza, Marielly CâmAra Rocha, Gustavo P. Amarante-Mendes

    Memory T cells are essential for effective and durable immune responses, as they provide long-term immunological surveillance and rapid reactivity upon re-exposure to a given pathogen or cancer cell. In solid tumors, the immunosuppressive tumor microenvironment (TME) often hinders immune activation, making enhancing memory T cell formation and persistence a key goal in cancer immunotherapy. Novel strategies are exploring ways to support these memory T cells, including using Listeria monocytogenes as a cancer vaccine vector. Notably, L. monocytogenes has unique properties that make it an ideal candidate for this purpose: it is highly effective at activating T cells, promoting the differentiation and survival of memory T cells, and modulating the TME to favor immune cell function. Thus, by leveraging the ability of L. monocytogenes to induce a strong, sustained T-cell response, researchers aim to develop vaccines that provide lasting immunity against tumors, reduce recurrence rates, and improve patient survival outcomes. This mini-review highlights the potential of memory T cell-focused cancer immunotherapy and the promising role of L. monocytogenes in advancing these efforts.


  • Open Access

    The Effect of Physical Activity on Cytokine Production: A Systematic Parallel Study of Horse and Human Athletes

    by Ifeoluwa Peace Oladapo, Abolaji Samson Olagunju, Olalekan Chris Akinsulie, Eduarda Proença, Ursula Yaeko Yoshitani, Marcelo Beltrão Molento

    Cytokines are glycoproteins responsible for cellular communication, influenced by exercise. Their levels vary depending on the intensity and type of physical activity in both humans and horses. This review aimed to assess the effects of various types and intensities of exercise on the production of pro- and anti-inflammatory cytokines. A systematic search (2000–2022) was performed using databases such as PubMed, Scopus, and Web of Science. Studies involving horses (n = 3) and/or humans (n = 21) undergoing physical activity were selected, resulting in 24 eligible articles. IL-6, TNF-α, and IL-10 levels increased after high-intensity exercise in both species, while moderate-intensity activity yielded more variable results. Some cytokines, such as IL-1β and IL-17, exhibited species-specific differences. Cytokine production is influenced by exercise intensity and duration. The observed differences between horses and humans suggest physiological divergences, warranting further research in the field of exercise immunology and other related disciplines. As a potential outcome of this work, we propose that horses could serve as an appropriate translational animal model for human athletes in exercise immunology, justifying a more comprehensive comparative approach.

  • Strive, Thrive & Survive: embracing challenges in pursuit of passion

    by Abolaji Samson Olagunju

    Challenges don’t last; embracing them is crucial to growth and success. Knowing and absorbing this is very important for students in any program and at any level in the academic world. I have my bachelor’s and master’s degrees from Ladoke Akintola University of Technology and University of Ibadan, Nigeria, respectively. Currently, I am a doctorate student at the Department of Immunology, University of Sao Paulo, Brazil. This article discusses my adaptation to a new environment, overcoming challenges, and the importance of support systems.

  • Open Access

    Long-Lasting, Fine-Tuned Anti-Tumor Activity of Recombinant Listeria monocytogenes Vaccine Is Controlled by Pyroptosis and Necroptosis Regulatory and Effector Molecules

    by Abolaji S. Olagunju, Andrew V. D. Sardinha, Gustavo P. Amarante-Mendes

    One of the main objectives of developing new anti-cancer vaccine strategies is to effectively induce CD8+ T cell-mediated anti-tumor immunity. Live recombinant vectors, notably Listeria monocytogenes, have been shown to elicit a robust in vivo CD8+ T-cell response in preclinical settings. Significantly, it has been demonstrated that Listeria induces inflammatory/immunogenic cell death mechanisms such as pyroptosis and necroptosis in immune cells that favorably control immunological responses. Therefore, we postulated that the host’s response to Listeria-based vectors and the subsequent induction of CD8+ T cell-mediated immunity would be compromised by the lack of regulatory or effector molecules involved in pyroptosis or necroptosis. To test our hypothesis, we used recombinant L. monocytogenes carrying the ovalbumin gene (LM.OVA) to vaccinate wild-type (WT), caspase-1/11−/−, gsdmd−/−, ripk3−/−, and mlkl−/− C57Bl/6 mice. We performed an in vivo cytotoxicity assay to assess the efficacy of OVA-specific CD8+ T lymphocytes in eliminating target cells in wild-type and genetically deficient backgrounds. Furthermore, we evaluated the specific anti-tumor immune response in mice inoculated with the B16F0 and B16F0.OVA melanoma cell lines. Our findings demonstrated that while caspase-1/11 and GSDMD deficiencies interfere with the rapid control of LM.OVA infection, neither of the KOs seems to contribute to the early activation of OVA-specific CTL responses. In contrast, the individual deficiency of each one of these proteins positively impacts the generation of long-lasting effector CD8+ T cells.


  • Open Access

    not-yet-known not-yet-known not-yet-known unknown Strive, Thrive, & Survive: Embracing Challenges in Pursuit of Passion

    by Abolaji Olagunju

    Challenges don’t last; embracing them is crucial to growth and success. Knowing and absorbing this, is very important for students in any program and at any level in the academic world. This article discussed my adaptation to a new environment, overcoming challenges, and the importance of support systems.

  • Open Access

    Long-Lasting, Fine-Tuned Anti-tumor Activity of Recombinant Listeria monocytogenes Vaccine Is Controlled by Pyroptosis and Necroptosis Regulatory and Effector Molecules

    by Abolaji Samson Olagunju, Andrew V. D. Sardinha, Gustavo P. Amarante-Mendes

    One of the main objectives of developing new anti-cancer vaccine strategies is to effectively induce CD8+ T cell-mediated anti-tumor immunity. Live recombinant vectors, notably Listeria mono-cytogenes, have been shown to elicit a robust in vivo CD8+ T cell response in preclinical settings. Significantly, it has been demonstrated that Listeria induces inflammatory/immunogenic cell death mechanisms such as pyroptosis and necroptosis in immune cells that favorably control immunological responses. Therefore, we postulated that the host's response to Listeria-based vec-tors and the subsequent induction of CD8+ T cell-mediated immunity would be compromised by the lack of regulatory or effector molecules involved in pyroptosis or necroptosis. To test our hy-pothesis, we used recombinant L. monocytogenes carrying the ovalbumin gene (LM.OVA) to vac-cinate wild-type (WT), caspase-1/11-/-, gsdmd-/-, ripk3-/-, and mlkl-/- C57Bl/6 mice. We performed an in vivo cytotoxicity assay to assess the efficacy of OVA-specific CD8+ T lymphocytes in eliminat-ing target cells in wild-type and genetically deficient backgrounds. Furthermore, we evaluated the specific anti-tumor immune response in mice inoculated with B16F0 and B16F0.OVA mela-noma cell lines. Our findings demonstrated that while caspase-1/11 and GSDMD deficiencies in-terfere with the rapid control LM.OVA infection, of the KO seems to contribute to the early acti-vation of OVA-specific CTL responses. In contrast, individual deficiency of each one of these pro-teins negatively impact the generation of long-lasting effector CD8+ T cells.


  • Open Access

    Mitochondrial dysfunction: A notable contributor to the progression of Alzheimer's and Parkinson's disease

    by Abolaji Samson Olagunju, Foysal Ahammad, Abiola Adeyanju Alagbe, Titilayomi Ayomide Otenaike, John Oluwafemi Teibo, Farhan Mohammad, Ahad Amer Alsaiari, Olabode Omotoso, Enamul Kabir Talukder


  • Open Access

    Recent developments in the significant effect of mRNA modification (M6A) in glioblastoma and esophageal cancer

    by Alfred Olaoluwa Akinlalu, Prisca Chinonso Njoku, Chisom Vivian Nzekwe, Rukayat Olayemi Oni, Toyosi Fojude, Akinwale John Faniyi, Abolaji Samson Olagunju

  • Open Access

    Mitochondrial Dysfunction: A Notable Contributor to the Progression of Alzheimer's and Parkinson's Disease

    by Abolaji Samson Olagunju, Abiola Adeyanju Alagbe, Titilayomi Ayomide Otenaike, Babatunde Oladayo Fabiyi, John Oluwafemi Teibo, Naeem Qusty, Safaa Qusti, Eida M. Alshammari, Gaber El-Saber Batiha, Olabode Omotoso

    Mitochondrial dysfunctions remained a pivotal mechanism in manifold neurodegenerative diseases. Mitochondrial homeostasis within the cell is an essential aspect of cell biology. Mitochondria which is also known as the power-generating set of the cell, have a dominant role in several processes associated with the genomic integrity and cellular equilibrium maintenance. They are involved in maintaining optimal cells functioning and guidance from possible DNA damage which could lead to mutations and onset of diseases. Conversely, system perturbations which could be due to environmental factors or senescence induce changes in the physiological balance and result in the mitochondrial functions impairment. Funding Statement: The project received no fund either from governmental or non-governmental organization. The project is self-funded by all authors. Declaration of Interests: The authors declare that they have no competing interests